Under the school’s disclosure rules, about 1,600 of 8,900 professors and lecturers at Harvard Medical School have reported to the dean that they or a family member had a financial interest in a business related to their teaching, research, or clinical care.”2 When professors publicly pass drug recommendations off as academic knowledge, we have a serious problem.